Open Access System for Information Sharing
All
Title
Author
Subject
Login
Library
Help
검색
HOME
Communities & Collections
Researchers
Title
Browse by Researchers
SUNG, YOUNG CHUL (성영철)
Div of Integrative Biosci & Biotech(융합생명공학부)
Field(s)
E-Mail
Homepage
Loading...
Export
Journal Papers
(International)
Journal Papers
(Domestic)
Conference Papers
(International)
Conference Papers
(Domestic)
Journal Papers(International)
Journal Papers(Domestic)
Conference Papers(International)
Conference Papers(Domestic)
30 items
100 items
200 items
Show more items...
H-INDEX
Chart.
Keyword
INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||sindbis:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||HUMANLYMPHOCYTES:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||experimental autoimmune encephalomyelitis:1||CLONAL EXPANSION:1||NGlycan:1||CHEMOKINE RECEPTORS:1||CYTOKINE PRODUCTION:1||MURINE MODEL:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||BREASTCANCER:1||envelope proteins:1||HYPERVARIABLE REGION1:1||MEDIATED SIGNALTRANSDUCTION:1||SYNOVIAL FIBROBLASTS:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||LUNGCANCER CELLS:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||CPG MOTIFS:1||REGION:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CLASSII TRANSACTIVATOR:1||NAIVE:1||LYMPHOCYTE RESPONSES:1||CANCERCELLS:1||SUBUNIT VACCINE:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||INTRATUMORAL INJECTION:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||interference:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||INDUCIBLE PROTEIN10:1||BCELLS:1||Suppression:1||CD8(+):1||injection route:1||PD1:1||Mycobacterium tuberculosis:1||RAS:1||ACCELERATION:1||coinfection:1||RISK:1||INVOLVEMENT:1||INFLAMMATORY DEMYELINATION:1||G(1) ARREST:1||peptide:1||vaginal adjuvant:1||ANAPHASE:1||core:1||MOLECULES:1||TRANSPORT:1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||RADICALS:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||recombinant:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||SIGNAL TRANSDUCER:1||BETA:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||NONA:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||GENOME:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MAMMALIANCELLS:5||MURINE:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TLYMPHOCYTE RESPONSES:4||TRANSGENIC MICE:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||INJECTION:3||Vaccine:3||HUMAN CANCERS:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||CUTTING EDGE:3||MECHANISM:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||hepatocellular carcinoma:3||ANTIGENPRESENTING CELLS:3||CANCERTHERAPY:3||P40 HOMODIMER:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||RNA:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||DEATH:3||GENE:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||plasmid DNA vaccine:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||RECENT PROGRESS:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||APOPTOSISINDUCING LIGAND:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||DIFFERENTIATION:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||Influenza:2||CYTOKINE:2||EOSINOPHILIA:2||CENTRALNERVOUSSYSTEM:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||INVITRO:2||COACTIVATORS:2||PHARMACODYNAMICS:2||PROMOTER:2||VIRUSINFECTION:2||EFFICACY:2||PHASEI:2||KINETOCHORE LOCALIZATION:2||RAT EMBRYO FIBROBLASTS:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||PROTEINKINASE:2||RESONANCE:2||DOMAIN:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||CD4(+):2||biodistribution:2||DELIVERY:2||BCG:2||ERtargeted haemagglutinin:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||NS3/4A:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||MHC CLASSI:2||Electroporation:2||HOMEOSTASIS:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||adjuvant Saponin:2||TUMOR:2||EXPRESSION VECTOR:2||protease:2||LESS PROMOTER:2||VALDMET:2||SELECTIVE STIMULATION:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||PROTEINS:2||HEMAGGLUTININ:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||TCELL HOMEOSTASIS:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||Ag85A:2||hepatocarcinogenesis:2||TRANSGOLGI NETWORK:2||IL12 PRODUCTION:2||MOTIFS:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||STEMCELLS:2||Hybrid Fc:2||IFNGAMMA:2||core protein:2||TSLP:2||COLONYSTIMULATING FACTOR:2||influenza infection:2||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||Th1CD4(+) Tcell response:1||GX12:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||interleukin12:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||G(1):1||G(1)CYCLINS:1||NONAHEPATITIS:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||DCs:1||TCR:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||asthma:1||dG(6)run:1||WAF1/CIP1:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||HETERODIMERIC CYTOKINE:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||Fc fusion protein:1||FAS LIGAND:1||3RD SIGNAL:1||RECOMBINANT ADENOVIRUSES:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||mesenchymal stem cell:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||GLYCOPROTEIN:1||RANKL:1||Flagellin:1||Fas:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||TH1 CELLS:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||IFNgamma:1||TRANSCRIPTION:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||RESISTANT:1||MESENCHYMAL STEMCELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||REPAIR:1||therapeutic vaccine:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||CpG oligodeoxynucleotides:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||BETA TCELLS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||MHC class II:1||IL4:1||prophylactic model:1||tuberculosis:1||Flt3L:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||IL18:1||41BB (CD137):1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||TOLERANCE:1||PHOSPHATIDYLINOSITOL 3KINASE:1||TRANSCRIPTIONAL REPRESSION:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||GROWTH SUPPRESSION:1||ARREST:1||AQUEOUSSOLUTION:1||TH1 RESPONSES:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||CHRONIC NONA:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||transgenic mouse:1||TISSUE DISTRIBUTION:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||Matrigel:1||LUNG METASTASIS MODEL:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||cyclin E:1||STIMULATION:1||Treg:1||SUPPRESSOR COMMITMENT:1||CROSSTALK:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||RETINOBLASTOMA PROTEIN:1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||